Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more

April 12, 2024

The latest news for pharma industry insiders.

Evaluating the Long-Term Clinical Benefit of Cancer Treatments Granted Accelerated Approval

April 11, 2024

A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.

Pharma Strategies for Succeeding Amid Strong Headwinds

April 11, 2024

Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.

Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more

April 11, 2024

The latest news for pharma industry insiders.

Maersk Welcomes New Facility in Sri Lanka

April 10, 2024

Wattala warehouse is expected to offer both export consolidation and 3PL services for trade routes that link Africa, Asia, and Europe.

Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more

April 10, 2024

The latest news for pharma industry insiders.